华邦健康 (002004)

HUAPONT LIFE SCIENCES CO., LTD.

ASZ

Tags

Generic DrugsImmunotherapyAgricultural ChemicalsSpin-off ListingsInnovative DrugsChemical IndustryMedical Aesthetics ConceptInvestments in Newly Listed CompaniesGuozheng Agriculture IndexInfant and Child ConceptNew MaterialsTourism ConceptSmart HealthcarePrivate HospitalsBelow Net Asset ValueGlyphosatePest ControlMargin Trading and Securities LendingSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 197991.92
  • Circulating A-Shares(W): 188161.94
  • Earnings Per Share(RMB): 0.3101
  • Net Assets Per Share(RMB): 4.8986
  • Operating Revenue(W RMB): 908598.84
  • Total Profit(W RMB): 108734.03
  • Net Profit Attributable to Parent(W RMB): 61182.04
  • Net Profit Growth Rate(%): 35.37
  • Weighted Return on Equity(%): 6.3800
  • Operating Cash Flow Per Share(RMB): 0.5720
  • Undistributed Profit Per Share(RMB): 0.9168
  • Capital Reserve Per Share(RMB): 2.7444

2. Main Business

The main business covers:

  • Pharmaceuticals
  • Medical Services
  • Agricultural Chemicals
  • New Materials
  • Tourism

3. Company Basic Information

  • Company Name: Huapont Life Sciences Co., Ltd.
  • Listing Date: 2004-06-25
  • Industry: Chemicals - Agricultural Chemicals
  • Address: No. 69, Xingguang Avenue, Renhe, Yubei District, Chongqing
  • Website: www.huapont.com.cn
  • Company Profile: The predecessor of the company was Chongqing Huapont Biochemical Technology Co., Ltd., which was established on March 11, 1992, as a limited liability company with a registered capital of 500,000 RMB. On September 16, 1994, it was renamed Chongqing Huapont Pharmaceutical Co., Ltd., and its registered capital increased to 1.5 million RMB. On September 19, 2001, Chongqing Huapont Pharmaceutical Co., Ltd. was transformed into Chongqing Huapont Pharmaceutical Co., Ltd., with a registered capital of 66 million RMB.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Chongqing Huibang Zhuoyuan Technology Co., Ltd. General Legal Person 37044.98 19.69
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 3160.93 1.68
3 Shanghai Zhuchi Asset Management Co., Ltd. - Zhuchi New Income Private Equity Investment Fund Phase 6 Private Equity Investment Fund 1808.35 0.96
4 Xi'an Investment Holding Co., Ltd. General Legal Person 1562.50 0.83
5 Southern China Securities 1000 ETF Fund 1448.59 0.77
6 Guotai Haitong CSI 1000 Index Enhanced Securities Investment Fund Class A Fund 388.43 0.21
7 Guotai Haitong CSI 1000 Preferred Stock Initiated Securities Investment Fund Class A Fund 225.90 0.12
8 CITIC Securities CSI 1000 Index Enhanced Securities Investment Fund Class A Fund 53.62 0.03
9 Guotai Haitong Dividend Quantitative Stock Selection Hybrid Securities Investment Fund Class A Fund 48.87 0.03
10 Tianhong CSI Dividend Low Volatility 100 ETF Link Fund Class A Fund 1.65 0.00

5. Concept Sectors

  • Infant & Child Concept
  • Private Hospitals
  • Glyphosate
  • Immunotherapy
  • Smart Healthcare
  • Generic Drugs
  • Pest Control
  • Medical Aesthetics Concept
  • New Materials
  • Tourism Concept
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • Below Net Asset Value
  • Investment in New Listings
  • Spin-off Listing
  • Guozheng Agriculture Index
  • SME 300 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information